Investigation of the Molecular Mechanisms Preceding PDE4 Inhibitor-Induced Vasculopathy in Rats: Tissue Inhibitor of Metalloproteinase 1, a Potential Predictive Biomarker-Reference-Cited by-同舟云学术

Investigation of the Molecular Mechanisms Preceding PDE4 Inhibitor-Induced Vasculopathy in Rats: Tissue Inhibitor of Metalloproteinase 1, a Potential Predictive Biomarker

Published:2007-06-14 Issue:1 Volume:100 Page:238-247
ISSN:1096-6080
Container-title:Toxicological Sciences
language:en
Short-container-title:

Author:

Daguès Nicolas,Pawlowski Valérie,Sobry Cécile,Hanton Gilles,Borde Françoise,Soler Sylvain,Freslon Jean-Louis,Chevalier Stephan

Publisher

Oxford University Press (OUP)

Subject

Toxicology

Link

http://academic.oup.com/toxsci/article-pdf/100/1/238/16679291/kfm161.pdf

Reference39 articles.

1. Coronary arteriopathy in monkeys following administration of CI-1020, an endothelin A receptor antagonist;Toxicol. Pathol.,1999

2. Heme oxygenase-1 induction by hemin protects against gut ischemia/reperfusion injury;J. Surg. Res.,2004

3. Phosphodiesterase 4 (PDE4) inhibitors in asthma and chronic obstructive pulmonary disease (COPD);Prog. Drug Res.,1999

4. Controlling the False Discovery Rate: A practical and powerful approach to multiple testing;J.R. Stat. Soc. B,1995

5. Expression of matrix metalloproteinases in patients with Wegener's granulomatosis;Ann. Rheum. Dis.,2004

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of potential biomarker candidates of drug-induced vascular injury (DIVI) in rats using gene expression and histopathology data;2022-08-27

2. Universal Accessible Biomarkers of Drug-Induced Tissue Injury and Systemic Inflammation in Rat: Performance Assessment of TIMP-1, A2M, AGP, NGAL, and Albumin;Toxicological Sciences;2022-03-14

3. Chasing a Breath of Fresh Air in Cystic Fibrosis (CF): Therapeutic Potential of Selective HDAC6 Inhibitors to Tackle Multiple Pathways in CF Pathophysiology;Journal of Medicinal Chemistry;2022-02-11

4. Cardiovascular microphysiological systems (CVMPS) for safety studies – a pharma perspective;Lab on a Chip;2021

5. Advances in the Development of Phosphodiesterase-4 Inhibitors;Journal of Medicinal Chemistry;2020-04-07